Related Experiment Video
Updated: Aug 7, 2026

04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Indications for orbital exenteration in mucormycosis
Roderick N Hargrove1, Ralph E Wesley, Kimberly A Klippenstein
1Department of Ophthalmology, The Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. rhargro1@utmem.edu
Ophthalmic Plastic and Reconstructive Surgery
|July 21, 2006
Summary
Evidence-based standards for orbital exenteration in mucormycosis are lacking. Further research is needed to guide treatment decisions and predict disease progression for better patient outcomes.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Surgical Oncology
Background:
- Orbital mucormycosis is a severe fungal infection requiring aggressive management.
- Orbital exenteration is a radical surgical procedure with significant morbidity.
- Current guidelines for orbital exenteration in mucormycosis are not well-established.
Purpose of the Study:
- To investigate the existence of evidence-based standards for orbital exenteration indications in orbital mucormycosis.
- To analyze factors influencing survival in patients with orbital mucormycosis.
- To assess current clinical practices and indications for exenteration among specialists.
Main Methods:
- A comprehensive literature review of 113 articles published between 1943 and 2004.
- Analysis of patient survival factors from published cases.
- A survey distributed to 34 ASOPRS Fellowship Preceptors regarding exenteration practices.
Main Results:
- Older age (>46 years), frontal sinus involvement, and fever were associated with decreased survival in mucormycosis.
- Amphotericin B treatment and diabetes were linked to improved survival.
- Exenteration in febrile patients showed a survival benefit (P=0.0468).
- Survey responses revealed varied exenteration indications and experiences among physicians.
Conclusions:
- Significant data gaps exist in evaluating orbital mucormycosis treatment.
- No established standard of care guides the use of exenteration for mucormycosis.
- Further research is essential to identify predictive variables for disease progression and optimize treatment strategies.